The DOI matches its Crossref record.
Performance and Cost-Effectiveness of Selective Screening Criteria for Chlamydia trachomatis Infection in Women: Implications for a National Chlamydia Control Strategy
Abstract
BACKGROUND AND OBJECTIVES: Detection of subclinical Chlamydia trachomatis infection in women is a high but costly public health priority. GOALS: To develop and test simple selective screening criteria for chlamydia in women, to assess the contribution of cervicitis to screening criteria, and to evaluate cost-effectiveness of selective versus universal screening. STUDY DESIGN: Cross-sectional study and cost-effectiveness analysis of 11,141 family planning (FP) and 19,884 sexually transmitted diseases (STD) female clients in Washington, Oregon, Alaska, and Idaho who were universally tested for chlamydia using cell culture, direct fluorescent antibody, enzyme immunoassay, or DNA probe. RESULTS: Prevalence of cervical chlamydial infection was 6.6%. Age younger than 20 years, signs of cervicitis, and report of new sex partner, two or more partners, or symptomatic partner were independent predictors of infection. Selective screening criteria consisting of age 20 years or younger or any partner-related risk detected 74% of infections in FP clients and 94% in STD clients, and required testing 53% of FP and 77% of STD clients. Including cervicitis in the screening criteria did not substantially improve their performance. Universal screening was more cost-effective than selective screening at chlamydia prevalences greater than 3.1% in FP clients and greater than 7% in STD clients. CONCLUSIONS: Age and behavioral history are as sensitive in predicting chlamydial infection as criteria that include cervicitis. Cost-effectiveness of selective screening is strongly influenced by the criteria's sensitivity in predicting infection, which was significantly higher in STD clients. At the chlamydia prevalences in the populations studied, it would be cost saving to screen universally in FP clinics and selectively in STD clinics, the reverse of current practice in many locales.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The Estimated Direct Medical Cost of Sexually Transmitted Diseases Among American Youth, 2000
Chesson, H. W., Blandford, J. M., Gift, T. L., Tao, G., & Irwin, K. L. (2004) · Perspectives on Sexual and Reproductive Health · doi:10.1363/3601104 · Cited by 444
(2002) · PsycEXTRA Dataset · doi:10.1037/e548392006-001 · Cited by 428
Burstein, G. R. (1998) · JAMA · doi:10.1001/jama.280.6.521 · Cited by 278
Chlamydia trachomatis Infections in Female Military Recruits
Gaydos, C. A., Howell, M. R., Pare, B., Clark, K. L., Ellis, D. A., Hendrix, R. M., Gaydos, J. C., McKee, K. T., & Quinn, T. C. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809103391105 · Cited by 262
Metadata
- Authors
- MARRAZZO, J. M., CELUM, C. L., HILLIS, S. D., FINE, D., DeLISLE, S., & HANDSFIELD, H. H.
- Venue
- Sexually Transmitted Diseases
- Published
- 1997-03
- Volume
- 24
- Issue
- 3
- Pages
- 131-141
- ISSN
- 0148-5717 (ISSN-L)
- OpenAlex
- W2094376275
- Cited by
- 193
- References
- 0
- FWCI
- 10.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Performance and Cost-Effectiveness of Selective Screening Criteria for Chlamydia trachomatis Infection in Women: Implications for a National Chlamydia Control Strategy. https://app.cochat.ai/papers/10.1097/00007435-199703000-00003
- The paper
- MARRAZZO, J. M., CELUM, C. L., HILLIS, S. D., FINE, D., DeLISLE, S., & HANDSFIELD, H. H. (1997). Performance and Cost-Effectiveness of Selective Screening Criteria for Chlamydia trachomatis Infection in Women: Implications for a National Chlamydia Control Strategy. Sexually Transmitted Diseases. https://doi.org/10.1097/00007435-199703000-00003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.